Article in Nature biomedical engineering, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Han DongDepartment of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA.
Yong LiangDivision of Hematologic Malignancies and Transplantation, Dana-Farber Cancer Institute, Boston, MA, USA.
Douglas BrownKoch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
Rizwan RomeeDivision of Hematologic Malignancies and Transplantation, Dana-Farber Cancer Institute, Boston, MA, USA.
Jianzhu ChenKoch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA. jchen@mit.edu.ORCID http://orcid.org/0000-0002-5687-6154
Funding
Novel Serum, Plasma, and Urine Biomarkers of Ovarian CanP50CA105009 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI CRAMER, DANIEL WILLIAM · 2004 to 2010
$13.3M
PROTEOMIC/EPIDMIOLOGIC PATHS TO OVARIAN CANCER SCREENINGU01CA086381 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI CRAMER, DANIEL WILLIAM · 2000 to 2010
$9.0M
Mucins and immune cell interactions in ovarian cancer pathogenesis & progressionR35CA197605 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI CRAMER, DANIEL WILLIAM · 2016 to 2022
$6.9M
OVARIAN CANCER RISK AND HYPERGONADOTROPIC HYPOGONADISMR01CA054419 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI CRAMER, DANIEL WILLIAM · 1992 to 2007
$5.9M
Development and Maintenance of Memory CD8 T CellsR01AI069208 · NIAID · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI CHEN, JIANZHU · 2006 to 2010
$2.0M
Therapeutic modulation of the phagocytosis axis as a novel glioblastoma immunotherapyR01NS104315 · NINDS · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI KIM, BETTY · 2018 to 2022
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Author Correction: CAR-T cells targeting a nucleophosmin neoepitope exhibit potent specific activity in mouse models of acute myeloid leukaemia. · full record | OpenQuestion